Host SUMOylation Pathway Negatively Regulates Protective Immune Responses and Promotes Leishmania donovani Survival. 2022

Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.

SUMOylation is one of the post-translational modifications that have recently been described as a key regulator of various cellular, nuclear, metabolic, and immunological processes. The process of SUMOylation involves the modification of one or more lysine residues of target proteins by conjugation of a ubiquitin-like, small polypeptide known as SUMO for their degradation, stability, transcriptional regulation, cellular localization, and transport. Herein, for the first time, we report the involvement of the host SUMOylation pathway in the process of infection of Leishmania donovani, a causative agent of visceral leishmaniasis. Our data revealed that infection of L. donovani to the host macrophages leads to upregulation of SUMOylation pathway genes and downregulation of a deSUMOylating gene, SENP1. Further, to confirm the effect of the host SUMOylation on the growth of Leishmania, the genes associated with the SUMOylation pathway were silenced and parasite load was analyzed. The knockdown of the SUMOylation pathway led to a reduction in parasitic load, suggesting the role of the host SUMOylation pathway in the disease progression and parasite survival. Owing to the effect of the SUMOylation pathway in autophagy, we further investigated the status of host autophagy to gain mechanistic insights into how SUMOylation mediates the regulation of growth of L. donovani. Knockdown of genes of host SUMOylation pathway led to the reduction of the expression levels of host autophagy markers while promoting autophagosome-lysosome fusion, suggesting SUMOylation-mediated autophagy in terms of autophagy initiation and autophagy maturation during parasite survival. The levels of reactive oxygen species (ROS) generation, nitric oxide (NO) production, and pro-inflammatory cytokines were also elevated upon the knockdown of genes of the host SUMOylation pathway during L. donovani infection. This indicates the involvement of the SUMOylation pathway in the modulation of protective immune responses and thus favoring parasite survival. Taken together, the results of this study indicate the hijacking of the host SUMOylation pathway by L. donovani toward the suppression of host immune responses and facilitation of host autophagy to potentially facilitate its survival. Targeting of SUMOylation pathway can provide a starting point for the design and development of novel therapeutic interventions to combat leishmaniasis.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007893 Leishmania donovani A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (Leishmania) donovani,Leishmania leishmania donovani,Leishmania donovanus,Leishmania leishmania donovanus,donovani, Leishmania leishmania,donovanus, Leishmania,donovanus, Leishmania leishmania,leishmania donovanus, Leishmania
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D010271 Parasites Invertebrate organisms that live on or in another organism (the host), and benefit at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically. Parasite
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D058207 Sumoylation A type of POST-TRANSLATIONAL PROTEIN MODIFICATION by SMALL UBIQUITIN-RELATED MODIFIER PROTEINS (also known as SUMO proteins). SUMO-Conjugation,SUMO Conjugation,SUMO-Conjugations,Sumoylations

Related Publications

Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
January 2021, Frontiers in cellular and infection microbiology,
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
July 2021, Biomolecular concepts,
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
January 2024, Acta tropica,
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
February 2015, Parasitology international,
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
August 2017, Journal of immunology (Baltimore, Md. : 1950),
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
September 2022, iScience,
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
January 1998, Research in immunology,
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
January 2020, Parasite immunology,
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
April 2019, The EMBO journal,
Jhalak Singhal, and Evanka Madan, and Ayushi Chaurasiya, and Pallavi Srivastava, and Niharika Singh, and Shikha Kaushik, and Amandeep Kaur Kahlon, and Mukesh Kumar Maurya, and Manisha Marothia, and Prerna Joshi, and Anand Ranganathan, and Shailja Singh
December 2023, Biochimie,
Copied contents to your clipboard!